![Biotechnology / Biology / Medicine / Recombinant proteins / Specialty drugs / Biosimilar / Drugs / Biopharmaceutical / Trastuzumab / Mylan / Pegfilgrastim / Filgrastim Biotechnology / Biology / Medicine / Recombinant proteins / Specialty drugs / Biosimilar / Drugs / Biopharmaceutical / Trastuzumab / Mylan / Pegfilgrastim / Filgrastim](https://www.pdfsearch.io/img/aed11e4c50e6d95c017448c56fda0ae0.jpg) Date: 2016-07-21 09:25:25Biotechnology Biology Medicine Recombinant proteins Specialty drugs Biosimilar Drugs Biopharmaceutical Trastuzumab Mylan Pegfilgrastim Filgrastim | | Press Release Mylan & Biocon Announce Regulatory Submission for Proposed Biosimilar Pegfilgrastim Accepted for Review by European Medicines Agency BENGALURU, India and HERTFORDSHIRE, England/PITTSBURGH, USA, July 21, 20Add to Reading ListSource URL: www.biocon.comDownload Document from Source Website File Size: 437,77 KBShare Document on Facebook
|